Motzer RJ - Search Results

1

A brief symptom index for advanced renal cell carcinoma.

Eton DT, Cella D, Bacik J, Motzer RJ. Eton DT, et al. Among authors: motzer rj. Health Qual Life Outcomes. 2006 Sep 26;4:68. doi: 10.1186/1477-7525-4-68. Health Qual Life Outcomes. 2006. PMID: 17002808 Free PMC article.

2

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J. Motzer RJ, et al. J Clin Oncol. 1999 Aug;17(8):2530-40. doi: 10.1200/JCO.1999.17.8.2530. J Clin Oncol. 1999. PMID: 10561319

3

Effect of cytokine therapy on survival for patients with advanced renal cell carcinoma.

Motzer RJ, Mazumdar M, Bacik J, Russo P, Berg WJ, Metz EM. Motzer RJ, et al. J Clin Oncol. 2000 May;18(9):1928-35. doi: 10.1200/JCO.2000.18.9.1928. J Clin Oncol. 2000. PMID: 10784634

4

Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer.

Motzer RJ, Sheinfeld J, Mazumdar M, Bains M, Mariani T, Bacik J, Bajorin D, Bosl GJ. Motzer RJ, et al. J Clin Oncol. 2000 Jun;18(12):2413-8. doi: 10.1200/JCO.2000.18.12.2413. J Clin Oncol. 2000. PMID: 10856101 Clinical Trial.

5

Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma.

Motzer RJ, Murphy BA, Bacik J, Schwartz LH, Nanus DM, Mariani T, Loehrer P, Wilding G, Fairclough DL, Cella D, Mazumdar M. Motzer RJ, et al. J Clin Oncol. 2000 Aug;18(16):2972-80. doi: 10.1200/JCO.2000.18.16.2972. J Clin Oncol. 2000. PMID: 10944130 Clinical Trial.

6

Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum.

Vuky J, Bains M, Bacik J, Higgins G, Bajorin DF, Mazumdar M, Bosl GJ, Motzer RJ. Vuky J, et al. Among authors: motzer rj. J Clin Oncol. 2001 Feb 1;19(3):682-8. doi: 10.1200/JCO.2001.19.3.682. J Clin Oncol. 2001. PMID: 11157018 Clinical Trial.

7

Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy.

Mazumdar M, Bajorin DF, Bacik J, Higgins G, Motzer RJ, Bosl GJ. Mazumdar M, et al. Among authors: motzer rj. J Clin Oncol. 2001 May 1;19(9):2534-41. doi: 10.1200/JCO.2001.19.9.2534. J Clin Oncol. 2001. PMID: 11331333

8

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma.

Motzer RJ, Bacik J, Murphy BA, Russo P, Mazumdar M. Motzer RJ, et al. J Clin Oncol. 2002 Jan 1;20(1):289-96. doi: 10.1200/JCO.2002.20.1.289. J Clin Oncol. 2002. PMID: 11773181

9

Salvage chemotherapy for patients with advanced pure seminoma.

Vuky J, Tickoo SK, Sheinfeld J, Bacik J, Amsterdam A, Mazumdar M, Reuter V, Bajorin DF, Bosl GJ, Motzer RJ. Vuky J, et al. Among authors: motzer rj. J Clin Oncol. 2002 Jan 1;20(1):297-301. doi: 10.1200/JCO.2002.20.1.297. J Clin Oncol. 2002. PMID: 11773182

10

Phase II trial of thalidomide for patients with advanced renal cell carcinoma.

Motzer RJ, Berg W, Ginsberg M, Russo P, Vuky J, Yu R, Bacik J, Mazumdar M. Motzer RJ, et al. J Clin Oncol. 2002 Jan 1;20(1):302-6. doi: 10.1200/JCO.2002.20.1.302. J Clin Oncol. 2002. PMID: 11773183 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

617 results

Search Page

Filters